CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Placebo control +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04628624
NCT04628624N/ACompleted

The Effect of Green Tea Supplementation Strategies on Fat Oxidation and Body Composition in Overweight Individuals

Anglia Ruskin University·interventional·Posted Nov 13, 2020·Updated Nov 13, 2020

In Brief

A clinical study evaluating Placebo control, GTE 1, and 1 other intervention for Overweight and Obesity and Fat Burn. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate the effects of green tea extract (GTE) on fat oxidation, body composition and exercise performance in overweight individuals. The study will be conducted under laboratory conditions following an 8 week supplemental period. Participants will be required to attend the laboratory for a pre-screening/familiarisation trial followed by assessments at week 0 (baseline), week 2, 4 and 8. Across the intervention, participants will maintain habitual dietary intake and follow a prescribed exercise programme. Additionally participants will be randomised to either a placebo, green tea extract or GTE with antioxidant supplementation. It is hypothesised that the addition of antioxidants with GTE will enhance fat oxidation in overweight individuals more than GTE or placebo. It is further hypothesised that such improvements in fat oxidation due to GTE will lead to improvements in both body composition variables and submaximal exercise performance (metabolic efficiency) in overweight, but otherwise healthy persons.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 13, 2020
Enrollment StartDec 1, 2018
Primary CompletionDec 1, 2019
Study CompletionMar 1, 2020
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 5.6 years ago

Interventions

Placebo controldietary

8 week supplementation period, with participants consuming 2 capsules per day containing potato starch

GTE 1dietary

8 week supplementation period, with participants consuming 2 capsules per day containing green tea extract (571mg/d)

GTE 2dietary

8 week supplementation period, with participants consuming 2 capsules per day containing green tea extract with additional antioxidants (150mg of quercitin and 150mg of alpha lipoic acid)